Electrical devices (e.g., cardiac rhythm management and neurostimulation
devices) for contact with tissue are used in combination with an
anti-scarring agent (e.g., a cell cycle inhibitor) in order to inhibit
scarring that may otherwise occur when the devices are implanted within
an animal.
